Literature DB >> 24596236

Surgical and anatomic considerations in endoscopic revision of failed external dacryocystorhinostomy.

Jonathan Liang1, Kevin Hur, Shannath L Merbs, Andrew P Lane.   

Abstract

OBJECTIVE: To identify key anatomic considerations in endoscopic revision dacryocystorhinostomy (r-EnDCR) following failed external dacryocystorhinostomy (ExDCR). STUDY
DESIGN: Case series with chart review.
SETTING: Tertiary care academic medical center.
METHODS: A retrospective review of patients undergoing r-EnDCR after failed ExDCR over the past 6 years was performed. Those with primary or previous EnDCR, proximal nasolacrimal procedures, and nasolacrimal lesions were excluded. All patients had a preoperative maxillofacial computed tomography (CT) scan. Data were collected on patient demographics, clinical characteristics, and radiographic findings. A classification system for the anterior ethmoid-lacrimal fossa complex anatomy was developed.
RESULTS: Twenty-five r-EnDCRs were performed on 22 patients after failed ExDCR. Concurrent sinusitis and previous maxillofacial trauma were seen in 9% (2/22) of patients. CT scan demonstrated anterior ethmoid pneumatization with agger nasi cells in 88% (22/25) of patients, and 95% (21/22) of these partially overlapped the medial aspect of the lacrimal fossa, resulting in a DCR ostium located within the middle meatus. The presence of ipsilateral septal deviation, concha bullosa, and middle turbinate lateralization or scarring to the lateral nasal wall was seen in 24% (6/25).
CONCLUSIONS: In this case series, a large proportion of patients who had failed an ExDCR had an agger nasi cell, suggesting that variability of the anterior ethmoid anatomy may contribute to surgical failure following ExDCR. CT imaging and endoscopy, which are not always performed prior to ExDCR, can help to elucidate the pattern of agger nasi pneumatization as it relates to the lacrimal fossa and to optimize placement of the DCR ostium.

Entities:  

Keywords:  anatomy; endoscopic dacryocystorhinostomy; ethmoid; lacrimal fossa; revision

Mesh:

Year:  2014        PMID: 24596236     DOI: 10.1177/0194599814524700

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  7 in total

Review 1.  Comprehensive review on endonasal endoscopic sinus surgery.

Authors:  Rainer K Weber; Werner Hosemann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

2.  Multifactorial assessment is essential to maximize the likelihood of good outcomes after endoscopic dacryocystorhinostomy.

Authors:  Zhengcai Lou
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-25       Impact factor: 2.503

3.  Pseudodacryocystitis: paediatric case series of infected atypical ethmoid air cells masquerading as recurrent dacryocystitis.

Authors:  A Mohite; T Jenyon; B Manoj; S Sandramouli; K Foster; A Oates; A-L McDermott; M V Parulekar
Journal:  Eye (Lond)       Date:  2016-12-09       Impact factor: 3.775

4.  Avoiding dacryocystorhinostomy in cases of epiphora caused by inferior meatus obstruction.

Authors:  Dvir Koenigstein; Ran Ben Cnaan; Shay Keren; Igal Leibovitch; Ahmad Safadi; Roee Landsberg; Avraham Abergel
Journal:  Eye (Lond)       Date:  2018-05-18       Impact factor: 3.775

5.  External Dacryocystorhinostomy; Success Rate and Causes of Failure in Endoscopic and Pathologic Evaluations.

Authors:  Hassan Ghasemi; Sajedeh Asghari Asl; Mohammad Ebrahim Yarmohammadi; Farhad Jafari; Pupak Izadi
Journal:  Iran J Pathol       Date:  2017-07-01

6.  Etiologic analysis of 100 anatomically failed dacryocystorhinostomies.

Authors:  Tarjani Vivek Dave; Faraz Ali Mohammed; Mohammad Javed Ali; Milind N Naik
Journal:  Clin Ophthalmol       Date:  2016-07-28

7.  Teamwork Endoscopic Endonasal Surgery in Failed External Dacryocystorhinostomy.

Authors:  Mohammad Ebrahim Yarmohammadi; Hassan Ghasemi; Farhad Jafari; Pupak Izadi; Mohammadreza Jalali Nadoushan; Narges Saghari Chin
Journal:  J Ophthalmic Vis Res       Date:  2016 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.